NCT03735680View on ClinicalTrials.gov

A Study to Evaluate ONM-100, an Intraoperative Fluorescence Imaging Agent for the Detection of Cancer

PHASE2CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

August 9, 2019

Primary Completion Date

October 14, 2021

Study Completion Date

November 18, 2021

Conditions
Breast CancerHead and Neck Squamous Cell CarcinomaColorectal CancerProstate CancerOvarian CancerUrothelial CarcinomaNon-small Cell Lung Cancer
Interventions
DRUG

ONM-100

A polymer micelle covalently conjugated to indocyanine green.

Trial Locations (3)

19104

The University of Pennsylvania, Philadelphia

75390

The University of Texas Southwestern Medical Center, Dallas

77030

The University of Texas - M.D. Anderson Cancer Center, Houston

Sponsors
All Listed Sponsors
lead

OncoNano Medicine, Inc.

INDUSTRY

NCT03735680 - A Study to Evaluate ONM-100, an Intraoperative Fluorescence Imaging Agent for the Detection of Cancer | Biotech Hunter | Biotech Hunter